SCHEMBL5506874

SCHEMBL5506874

CCOc1cc(N(C)C)c(S(=O)(=O)N(C)C)cc1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.46
MAPT P10636 2/20 0.46
HSD17B10 Q99714 1/20 0.46
MCL1 Q07820 1/20 0.43
CYP3A4 P08684 1/20 0.39
ALDH1A1 P00352 5/20 0.38
KMT2A Q03164 4/20 0.38
LMNA P02545 2/20 0.38
MEN1 O00255 2/20 0.38
HTT P42858 1/20 0.38
KDM4E B2RXH2 2/20 0.38
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
GAA P10253 2/20 0.37
PKM P14618 1/20 0.37
RCE1 Q9Y256 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3997482 0.87 MAPT (0.47) TSHRMAPTHSD17B10CYP3A4ALDH1A1
SCHEMBL11452642 0.77 TSHR (0.50) TSHRMAPTHSD17B10MCL1CYP3A4
SCHEMBL4004644 0.74 TSHR (0.47) TSHRMAPTHSD17B10CYP3A4ALDH1A1
SCHEMBL2828736 0.74 TSHR (0.75) TSHRHSD17B10CYP3A4ALDH1A1KMT2A
SCHEMBL7797982 0.71 TSHR (0.50) TSHRHSD17B10CYP3A4ALDH1A1KMT2A
SCHEMBL22515407 0.71 CISD1 (0.39) TSHRMAPTHSD17B10ALDH1A1KMT2A
SCHEMBL29384448 0.71 CISD1 (0.39) TSHRMAPTHSD17B10ALDH1A1KMT2A
SCHEMBL4006354 0.71 TSHR (0.50) TSHRMAPTCYP3A4ALDH1A1KMT2A
SCHEMBL4001970 0.71 TSHR (0.47) TSHRMAPTHSD17B10CYP3A4ALDH1A1
SCHEMBL4001527 0.71 TSHR (0.56) TSHRMAPTALDH1A1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1861376-A1 CIS-2,4,5-TRIARYL-IMIDAZOLINES AND THEIR USE AS ANTI-CANCER MEDICAMENTS F. Hoffmann-Roche AG (CH) 2007-12-05 EP disclosed
WO-2006097261-A1 CIS-2,4,5-TRIARYL-IMIDAZOLINES AND THEIR USE AS ANTI-CANCER MEDICAMENTS F.HOFFMANN-LA ROCHE AG (CH) 2006-09-21 WO disclosed